Atlas Trials

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Clinical trial NCT01309737 · COMPLETED

Trial details

NCT number
NCT01309737
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriasis
Start date
2011-03-01
Primary completion
2013-04-01
Enrollment
960

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.